Literature DB >> 23064506

Advancements in pressure-volume catheter technology - stress remodelling after infarction.

James E Clark1, Michael S Marber.   

Abstract

Microconductance catheters have been successfully applied to measure left ventricular (LV) function in the mouse to assess cardiac or pharmacological interventions for a number of years. New complex admittance methods produce an estimate of the parallel admittance of cardiac muscle that can be used to correct the measurement in real time. This contrasts with existing conductance technologies that require in vivo calibration using a bolus of hypertonic saline. Here, we report the application of this emerging technology in the context of myocardial infarction and LV remodelling. Using a combination of high-resolution ultrasound and LV conductance catheters, we compared measures of LV function using an admittance system and a traditional conductance-derived pressure-volume (PV) system. We subjected C57BL/6 mice to focal myocardial ischaemia-reperfusion by transient ligation of the left anterior descending coronary artery and assessed cardiac function with different systems to determine the reliability and accuracy of these methods to distinguish between normal and dysfunctional ventricle. We demonstrate that the admittance PV system, in our hands, provides a straightforward solution for assessing LV function in mice. Using this technique in combination with other established methods, we measured LV dysfunction following coronary artery occlusion and reperfusion, which can be ameliorated using a known preconditioning agent (CORM-3), and found that functional read-outs are representative of other methods. We have found that, especially in diseased tissue, LV pressure-volume loops derived from complex admittance provide a reproducible and reliable method of determining LV function without the need for technically challenging calibration. Our data suggest that admittance records accurate/physiological LV cavity volumes when compared with other invasive methods in the same animal. This emerging technology is both effective and reproducible for measuring LV function and dysfunction in the mouse, without the need for complicated interventions to calibrate the measurements or training in a new technology. This may mark the way towards a fast and accurate assessment of murine cardiac function in normal animals and disease models.

Entities:  

Mesh:

Year:  2012        PMID: 23064506     DOI: 10.1113/expphysiol.2012.064733

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  9 in total

1.  An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography.

Authors:  Zach Rozenbaum; Yaron Arbel; Yoav Granot; Dotan Cohen; Haim Shmilovich; Tomer Ziv-Baran; Ehud Chorin; Ofer Havakuk; Merav Cohen; Shlomo Berliner; Yan Topilsky; Galit Aviram
Journal:  Clin Cardiol       Date:  2017-06-14       Impact factor: 2.882

2.  Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice.

Authors:  Dennis Abraham; Lan Mao
Journal:  J Vis Exp       Date:  2015-09-17       Impact factor: 1.355

Review 3.  The Pitfalls of in vivo Cardiac Physiology in Genetically Modified Mice - Lessons Learnt the Hard Way in the Creatine Kinase System.

Authors:  Craig A Lygate
Journal:  Front Physiol       Date:  2021-05-14       Impact factor: 4.566

4.  p38γ MAPK contributes to left ventricular remodeling after pathologic stress and disinhibits calpain through phosphorylation of calpastatin.

Authors:  Aminah A Loonat; E Denise Martin; Negin Sarafraz-Shekary; Katharina Tilgner; Nicholas T Hertz; Rebecca Levin; Kevan M Shokat; Alma L Burlingame; Pelin Arabacilar; Shahzan Uddin; Max Thomas; Michael S Marber; James E Clark
Journal:  FASEB J       Date:  2019-10-22       Impact factor: 5.834

5.  Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac Transplant.

Authors:  E Sharif-Paghaleh; M L Yap; L L Meader; K Chuamsaamarkkee; F Kampmeier; A Badar; R A Smith; S Sacks; G E Mullen
Journal:  Am J Transplant       Date:  2015-04-23       Impact factor: 8.086

6.  Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.

Authors:  Ehsan Sharif-Paghaleh; May Lin Yap; Sarah-Lena Puhl; Adam Badar; Julia Baguña Torres; Krisanat Chuamsaamarkkee; Florian Kampmeier; Richard A Smith; James Clark; Philip J Blower; Steven Sacks; Gregory E Mullen
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

7.  The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.

Authors:  Laura Mele; Lauren J Maskell; Daniel J Stuckey; James E Clark; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2019-08-14       Impact factor: 8.469

8.  A tissue-engineered scale model of the heart ventricle.

Authors:  Luke A MacQueen; Sean P Sheehy; Christophe O Chantre; John F Zimmerman; Francesco S Pasqualini; Xujie Liu; Josue A Goss; Patrick H Campbell; Grant M Gonzalez; Sung-Jin Park; Andrew K Capulli; John P Ferrier; T Fettah Kosar; L Mahadevan; William T Pu; Kevin Kit Parker
Journal:  Nat Biomed Eng       Date:  2018-07-23       Impact factor: 25.671

9.  Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography.

Authors:  Omer Faruk Baycan; Hasan Ali Barman; Adem Atici; Adem Tatlisu; Furkan Bolen; Pınar Ergen; Sacit Icten; Baris Gungor; Mustafa Caliskan
Journal:  Int J Cardiovasc Imaging       Date:  2020-08-15       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.